The Cutting Edge of Medical Technology Content, Community & Collaboration
Biotech ... A Rough Year, But Life Science Tools May Offer 2010 Investment Opportunities
Colleagues,
As reported in GenomeWeb News ... Despite the fact that US biotechnology venture investment is at its lowest point since 2002, the outlook for the life science research tools sector remains positive due to a marked increase in innovation at universities and research institutions ...
... the life science tools market – which traditionally has not been as overtly appealing to investors as have markets such as therapeutics and medical devices – is an area that healthcare-oriented investors may consider targeting more frequently based on recent results...
... Illumina, Applied Biosystems, Sequenom, and Affymetrix are examples of companies that built strong market valuation based on enabling life science research tools, sometimes just with one key technology...
... innovation in the life science research tools sector may be at an all-time high ... and the academic sector is the major source of this innovation ... .. stimulus money moving into the academic centers will be a major driver that may be slow to materialize, but will ultimately be significant ... innovation should continue to grow as the bolus of federal stimulus funding provided over the last year by the NIH for cutting-edge biomedical research is disbursed ...
... Nonetheless, it will still be challenging getting a company launched out of academia or from an initial technology proof-of-concept stage to an acquisition ready commercial entity... it will be particularly difficult in an environment in which IPOs' (Initial Public Offerings) are rare, and financial exits are almost totally dependent on a limited number of Merger & Acquisition (M&A) candidates ...
... To realize returns on these investments, and to navigate these companies towards rewarding exits, will require skilled "Triple Helix" life cycle management that manages their growth and strategic partnerships from inception thru acquisition by an attractive strategic corporate investor ...
Read on at: http://www.genomeweb.com/investment-opportunities-abound-life-scien...
ENJOY!
CC
As reported in GenomeWeb News ... Despite the fact that US biotechnology venture investment is at its lowest point since 2002, the outlook for the life science research tools sector remains positive due to a marked increase in innovation at universities and research institutions ...
... the life science tools market – which traditionally has not been as overtly appealing to investors as have markets such as therapeutics and medical devices – is an area that healthcare-oriented investors may consider targeting more frequently based on recent results...
... Illumina, Applied Biosystems, Sequenom, and Affymetrix are examples of companies that built strong market valuation based on enabling life science research tools, sometimes just with one key technology...
... innovation in the life science research tools sector may be at an all-time high ... and the academic sector is the major source of this innovation ... .. stimulus money moving into the academic centers will be a major driver that may be slow to materialize, but will ultimately be significant ... innovation should continue to grow as the bolus of federal stimulus funding provided over the last year by the NIH for cutting-edge biomedical research is disbursed ...
... Nonetheless, it will still be challenging getting a company launched out of academia or from an initial technology proof-of-concept stage to an acquisition ready commercial entity... it will be particularly difficult in an environment in which IPOs' (Initial Public Offerings) are rare, and financial exits are almost totally dependent on a limited number of Merger & Acquisition (M&A) candidates ...
... To realize returns on these investments, and to navigate these companies towards rewarding exits, will require skilled "Triple Helix" life cycle management that manages their growth and strategic partnerships from inception thru acquisition by an attractive strategic corporate investor ...
Read on at: http://www.genomeweb.com/investment-opportunities-abound-life-scien...
ENJOY!
CC
Views: 6
MedTechIQ VideoLibrary
Upcoming Events
© 2024 Created by CC-Conrad Clyburn-MedForeSight.
Powered by
